Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page revision has been updated to v3.5.4. This indicates an updated site version rather than any modification to the study data or content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing Revision: v3.5.2, signaling a front-end/site version update. This change is administrative and does not modify the study data or visible content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed, indicating a minor software update.SummaryDifference0.0%

- Check36 days agoChange DetectedDifference0.0%

- Check58 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 with no visible changes to study content.SummaryDifference0.0%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.